What's new

Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive

Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive

Mar 12, 2025 - 17:06
 0
Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive
Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive
Read More

Tags:

Previous Article

Orphan designation: pelabresib monohydrate Treatment of myelofibrosis, 17/02/202...

Next Article

Orphan designation: Magrolimab Treatment of myelodysplastic syndromes, 26/06/202...

Related Posts

Human medicines European public assessment report (EPAR): Biktarvy, bictegravir,emtricitabine,tenofovir alafenamide, Date of authorisation: 21/06/2018, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

PSUSA/00002256/202407

PSUSA/00002256/202407

Mar 13, 2025  0

Clinical investigation of medicinal products in the treatment of depression - Scientific guideline

Clinical investigation of medicinal products in the tre...

Mar 12, 2025  0